# Study of 225Ac-PSMA-617 in Men With PSMA-positive Prostate Cancer

> **NCT04597411** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Endocyte** · enrollment: 101 (actual)

## Conditions studied

- Prostatic Neoplasms, Castration-Resistant

## Interventions

- **RADIATION:** 225^Ac-PSMA-617
- **RADIATION:** 68^Ga-PSMA-11

## Key facts

- **NCT ID:** NCT04597411
- **Lead sponsor:** Endocyte
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-04-01
- **Primary completion:** 2027-01-01
- **Final completion:** 2027-01-01
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2026-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04597411

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04597411, "Study of 225Ac-PSMA-617 in Men With PSMA-positive Prostate Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04597411. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*